SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001328143-21-000095
Filing Date
2021-11-24
Accepted
2021-11-24 16:11:37
Documents
1
Period of Report
2021-11-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163778827988800.html 4  
1 FORM 4 wf-form4_163778827988800.xml 4 11813
  Complete submission text file 0001328143-21-000095.txt   13253
Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address
BIGHAM MICHAEL (Reporting) CIK: 0001216917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 211446762

Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences